NN Investment Partners Holdings’s AstraZeneca AZN Stock Holding History

NN Investment Partners Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,387	Closed	-$3.53M	–	790
2021 Q3	$3.53M	Buy	29,387 +24,038	+449%	+$2.8M	0.02%	478
2021 Q2	$641K	Buy	+5,349	New	+$587K	﹤0.01%	701
2016 Q3	–	Sell	-15,278	Closed	-$922K	–	873
2016 Q2	$922K	Buy	+15,278	New	+$887K	0.01%	478

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

NN Investment Partners Holdings's AZN Position: Q4 2021 in Review

NN Investment Partners Holdings sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 29,387 shares — an estimated $3.53M sold.

NN Investment Partners Holdings first reported a position in AZN in Q2 2016 and held it in 3 quarters. The position peaked at $3.53M in Q3 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

NN Investment Partners Holdings reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
NN Investment Partners Holdings sold 29,387 AstraZeneca shares in Q4 2021, an estimated $3.53M.
NN Investment Partners Holdings first reported a position in AstraZeneca in Q2 2016 and held it in 3 quarters.
NN Investment Partners Holdings's AstraZeneca position peaked at $3.53M in Q3 2021.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on NN Investment Partners Holdings's 13F filing for Q4 2021, filed 27 Jan 2022.